| Autor: |
Pinkham MB; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia. Mark.pinkham@health.qld.gov.au.; University of Queensland, Brisbane, Australia. Mark.pinkham@health.qld.gov.au., Herschtal A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Hong AM; Department of Radiation Oncology, Chris O'Brien Lifehouse, Sydney, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Genesiscare, Mater Hospital, North Sydney, Australia., Chua MS; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VC, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Cumming S; Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, Australia., Pullar A; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia.; University of Queensland, Brisbane, Australia.; Queensland University of Technology, Brisbane, Australia., Nobes J; Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK., Barker CA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Guadagnolo BA; Department of Radiation Oncology, MD Anderson Cancer Centre, Houston, TX, USA., Fogarty GB; ICON Cancer Centre, Revesby, Australia., Burmeister BH; University of Queensland, Brisbane, Australia.; GenesisCare Fraser Coast, Hervey Bay, Australia., Foote MC; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia.; University of Queensland, Brisbane, Australia. |
Full text from SpringerLink